79 related articles for article (PubMed ID: 23768125)
1. ID3 contributes to cerebrospinal fluid seeding and poor prognosis in medulloblastoma.
Phi JH; Choi SA; Lim SH; Lee J; Wang KC; Park SH; Kim SK
BMC Cancer; 2013 Jun; 13():291. PubMed ID: 23768125
[TBL] [Abstract][Full Text] [Related]
2. Expression pattern of id proteins in medulloblastoma.
Snyder AD; Dulin-Smith AN; Houston RH; Durban AN; Brisbin BJ; Oostra TD; Marshall JT; Kahwash BM; Pierson CR
Pathol Oncol Res; 2013 Jul; 19(3):437-46. PubMed ID: 23397264
[TBL] [Abstract][Full Text] [Related]
3. ID3 is a novel target gene of p53 and modulates lung cancer cell metastasis.
Nagasaka M; Miyajima C; Inoue Y; Hashiguchi S; Suzuki Y; Morishita D; Aoki H; Toriuchi K; Katayama R; Aoyama M; Hayashi H
Biochem Biophys Res Commun; 2024 May; 708():149789. PubMed ID: 38513475
[TBL] [Abstract][Full Text] [Related]
4. Disease Evolution Monitored by Serial Cerebrospinal Fluid Liquid Biopsies in Two Cases of Recurrent Medulloblastoma.
O'Halloran K; Margol A; Davidson TB; Estrine D; Tamrazi B; Cotter JA; Ji J; Biegel JA
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732099
[TBL] [Abstract][Full Text] [Related]
5. ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination.
Jones JK; Zhang H; Lyne AM; Cavalli FMG; Hassen WE; Stevenson K; Kornahrens R; Yang Y; Li S; Dell S; Reitman ZJ; Herndon JE; Hoj J; Pendergast AM; Thompson EM
Neurooncol Adv; 2023; 5(1):vdad095. PubMed ID: 37781087
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.
Martirosian V; Deshpande K; Zhou H; Shen K; Smith K; Northcott P; Lin M; Stepanosyan V; Das D; Remsik J; Isakov D; Boire A; De Feyter H; Hurth K; Li S; Wiemels J; Nakamura B; Shao L; Danilov C; Chen T; Neman J
Cell Rep; 2021 Jul; 36(4):109475. PubMed ID: 34320362
[No Abstract] [Full Text] [Related]
7. Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma.
Jenkins NC; Kalra RR; Dubuc A; Sivakumar W; Pedone CA; Wu X; Taylor MD; Fults DW
Acta Neuropathol Commun; 2014 Jul; 2():85. PubMed ID: 25059231
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma subgroups remain stable across primary and metastatic compartments.
Wang X; Dubuc AM; Ramaswamy V; Mack S; Gendoo DM; Remke M; Wu X; Garzia L; Luu B; Cavalli F; Peacock J; López B; Skowron P; Zagzag D; Lyden D; Hoffman C; Cho YJ; Eberhart C; MacDonald T; Li XN; Van Meter T; Northcott PA; Haibe-Kains B; Hawkins C; Rutka JT; Bouffet E; Pfister SM; Korshunov A; Taylor MD
Acta Neuropathol; 2015 Mar; 129(3):449-57. PubMed ID: 25689980
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancer.
Chen D; Forootan SS; Gosney JR; Forootan FS; Ke Y
Genes Cancer; 2014 May; 5(5-6):212-25. PubMed ID: 25061504
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced motility alterations in medulloblastoma cells.
Rieken S; Rieber J; Brons S; Habermehl D; Rief H; Orschiedt L; Lindel K; Weber KJ; Debus J; Combs SE
J Radiat Res; 2015 May; 56(3):430-6. PubMed ID: 25736470
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells.
Justilien V; Fields AP
Clin Cancer Res; 2015 Feb; 21(3):505-13. PubMed ID: 25646180
[TBL] [Abstract][Full Text] [Related]
12. Medulloblastoma-translating discoveries from the bench to the bedside.
Gajjar AJ; Robinson GW
Nat Rev Clin Oncol; 2014 Dec; 11(12):714-22. PubMed ID: 25348790
[TBL] [Abstract][Full Text] [Related]
13. The Role of the Dysregulation of Long Non-Coding and Circular RNA Expression in Medulloblastoma: A Systematic Review.
Martinez de Estibariz I; Jakjimovska A; Illarregi U; Martin-Guerrero I; Gutiérrez-Camino A; Lopez-Lopez E; Bilbao-Aldaiturriaga N
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835380
[TBL] [Abstract][Full Text] [Related]
14. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-Dependent Kinase Inhibitor 2A is a Key Regulator of Cell Cycle Arrest and Senescence in Endothelial Colony-Forming Cells in Moyamoya Disease.
Choi SA; Moon YJ; Koh EJ; Phi JH; Lee JY; Kim KH; Kim SK
J Korean Neurosurg Soc; 2023 Nov; 66(6):642-651. PubMed ID: 37138505
[TBL] [Abstract][Full Text] [Related]
16. Exploration of potential key pathways and genes in multiple ocular cancers through bioinformatics analysis.
Wan Q; Tang J
Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2329-2341. PubMed ID: 31309275
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of DNA binding proteins: implications in human cancer progression and metastasis.
Ke J; Wu R; Chen Y; Abba ML
Am J Transl Res; 2018; 10(12):3887-3910. PubMed ID: 30662638
[TBL] [Abstract][Full Text] [Related]
18. Panobinostat, a histone deacetylase inhibitor, suppresses leptomeningeal seeding in a medulloblastoma animal model.
Phi JH; Choi SA; Kwak PA; Lee JY; Wang KC; Hwang DW; Kim SK
Oncotarget; 2017 Aug; 8(34):56747-56757. PubMed ID: 28915627
[TBL] [Abstract][Full Text] [Related]
19. Contribution of Inhibitor of DNA Binding/Differentiation-3 and Endocrine Disrupting Chemicals to Pathophysiological Aspects of Chronic Disease.
Avecilla V; Doke M; Felty Q
Biomed Res Int; 2017; 2017():6307109. PubMed ID: 28785583
[TBL] [Abstract][Full Text] [Related]
20. Blocking COX-2 induces apoptosis and inhibits cell proliferation via the Akt/survivin- and Akt/ID3 pathway in low-grade-glioma.
Sato A; Mizobuchi Y; Nakajima K; Shono K; Fujihara T; Kageji T; Kitazato K; Matsuzaki K; Mure H; Kuwayama K; Sumi A; Saya H; Sampetrean O; Nagahirao S
J Neurooncol; 2017 Apr; 132(2):231-238. PubMed ID: 28283800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
